Product Overview: Eriacta
Eriacta 100mg is a pharmaceutical-grade sildenafil citrate preparation developed for in-vitro research applications. As a selective phosphodiesterase-5 (PDE-5) inhibitor, this compound serves as a valuable tool for researchers studying vascular signalling pathways and cyclic guanosine monophosphate (cGMP) regulatory mechanisms. Sildenafil citrate represents a well-characterized compound with extensive documentation in peer-reviewed literature, making it an ideal reference standard for cardiovascular and enzymatic research protocols. Laboratories investigating nitric oxide-dependent signalling cascades frequently utilise sildenafil preparations to examine PDE-5 enzyme kinetics and downstream molecular effects. The pharmaceutical formulation ensures consistent potency and purity standards essential for reproducible experimental outcomes.
Our Stroid UK Shop maintains rigorous quality control protocols for all research compounds, with comprehensive analytical verification performed on each batch. Researchers studying comparative pharmacology often examine sildenafil alongside other investigational compounds available in our SARM catalogue and peptide research library to evaluate diverse molecular targets and therapeutic mechanisms.
Laboratory Applications
Investigators examining cardiovascular physiology utilise Eriacta 100mg to study PDE-5 inhibition effects on smooth muscle cell function and endothelial nitric oxide pathways. The compound demonstrates high selectivity for PDE-5 over other phosphodiesterase isoforms, enabling precise mechanistic studies of cGMP-dependent protein kinase activation. Research applications include analysis of vasorelaxation responses, pulmonary arterial pressure modulation, and cellular calcium homeostasis in various experimental models. Biochemistry laboratories frequently incorporate sildenafil into enzyme kinetic assays to characterise PDE-5 catalytic properties and inhibitor binding affinities. The standardised pharmaceutical preparation facilitates accurate dose-response curve generation and comparative potency assessments across different experimental conditions. Researchers can explore this compound alongside other specialised preparations in our comprehensive sildenafil research category.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 100mg per tablet |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Purity | Pharmaceutical grade |
Research Compliance
Eriacta 100mg is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate laboratory safety protocols and regulatory compliance when handling this compound. All experimental procedures should be conducted by qualified personnel in properly equipped research facilities with adequate ventilation and safety measures.
